Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ: EVO )

4.580 -0.010 (-0.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday! 
Via InvestorPlace
Why Germany-Based Life Science Company Evotec Shares Are Falling Today
Evotec SE (NASDAQ: EVO) shares are trading lower  
Via Benzinga
Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 50 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I
Via ACCESSWIRE
A Preview Of Evotec's Earnings
Via Benzinga
What 4 Analyst Ratings Have To Say About Evotec
Via Benzinga
Evotec's Earnings Outlook
Via Benzinga
Evotec Announces CEO Transition
Via ACCESSWIRE
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
Via ACCESSWIRE
Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases
Via ACCESSWIRE
Evotec-partner Jingxin Receives Approval for EVT201 in China
Via ACCESSWIRE
Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day
Via ACCESSWIRE
Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update
Via ACCESSWIRE
Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology
Via ACCESSWIRE
Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
Via ACCESSWIRE
Evotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D Economy
Via ACCESSWIRE
Evotec and Novo Nordisk Launch LAB eN² to Accelerate Translation in Cardiometabolic Diseases
Via ACCESSWIRE
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. 
Via Benzinga
Salesforce To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Thursday
Needham raised the price target for CrowdStrike Holdings, Inc. (NASDAQ: CRWD) from $170 to $200. Needham analyst Alex Henderson maintained a Buy rating. CrowdStrike shares rose 1.7% to close at $149.18... 
Via Benzinga
Evotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updates
Via ACCESSWIRE
Evotec SE Reports First Half-Year 2023 Results on 29 August 2023
Via ACCESSWIRE
Evotec Provides Update on Financial Impact of Cyber-Attack
Via ACCESSWIRE
Top Investment Bank Unveils 3 ETFs, 10 Stocks To Buy In The AI Boom
Via Benzinga
Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership
Via ACCESSWIRE
Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories
Reuters 
Via Benzinga
Evotec Secures US Government Contract For Orthopoxvirus Antibody
The U.S. 
Via Benzinga
Tesla, Bank OZK And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Just - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program
Via ACCESSWIRE
Evotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease Programme
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.